Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01504659
Recruitment Status : Terminated (Administrative issues)
First Posted : January 5, 2012
Last Update Posted : March 16, 2017
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2016
  Actual Study Completion Date : November 2016